Improved Survival in Rats Administered NG-Nitro L-Arginine Methyl Ester Due to Converting Enzyme Inhibition

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 1, 1996, Pages 142-148

  Michel, Jean Baptiste ^a   Xu, Yichun ^a   Blot, Stephane ^a   Philippe, Monique ^a   Chatellier, Gilles ^a  

^a INSERM   (France)

Author keywords

Cyclic gmp; Renal insufficiency; Renin angiotensin system; Stroke

Indexed keywords

CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; QUINAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; DRUG EFFECT; ENZYME INHIBITION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; SURVIVAL RATE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA; BLOOD PRESSURE; ENZYME INHIBITORS; ISOQUINOLINES; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; TETRAHYDROISOQUINOLINES;

EID: 0030003011     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199607000-00021     Document Type: Article

References (34)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42.
2. Gardner SM, Kemp PA, Bennett T, Palmer RMJ, Moncada S. Nitric oxide synthase inhibitors cause sustained, but reversible, hypertension and hindquarters vasoconstriction in Brattleboro rats. Eur J Pharmacol 1992;213:449-51.
3. Ribeiro MO, Antunes E, de Nucci G, et al. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 1992;20:298-303.
4. Arnal JF, Warin L, Michel JB. Determinations of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 1992;90:647-52.
5. Baylis C, Mitruka B, Deng AM. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992;90:278-81.
6. Xu Y, Arnal JF, Hinglais N, et al. Renal hypertension angiopathy. Comparison between chronic NO suppression and DOCA-salt intoxication. Am J Hypertens 1995;8:167-76.
7. Blot S, Arnal JF, Xu Y, et al. Spinal cord infarcts during long term inhibition of nitric oxide synthase in rats. Stroke 1994;25:1666-73.
8. Navarro J, Sanchez A, Saiz J, et al. Hormonal, renal, and metabolic alterations during hypertension induced by chronic inhibition of NO in rats. Am J Physiol 1994;267:R1516-21.
9. Arnal JF, El Amrani AIK, Chatellier G, et al. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 1993;22:380-7.
10. Morton JJ, Beatti EC, Speirs A, Gulliver F. Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat; role of renin and vascular hypertrophy. J Hypertens 1993;11:1083-8.
11. Pollock DM, Polakowski JJ, Divish BJ, Opgeworth TJ. Angiotensin blockade reverses hypertension during long term nitric oxide synthase inhibition. Hypertension 1993;21:660-6.
12. Jover B, Herizi A, Ventre F, Dupont M, Mimram A. Sodium and angiotensin in hypertension by long term nitric oxide blockade. Hypertension 1993;21:944-8.
13. -15 mole level. Anal Biochem 1976;70:195-202.
14. Honna M, Satoh T, Takezawa J, Ui M. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue. Biochem Med 1977;18:257-73.
15. Menard JM, Catt KJ. Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology 1972;90:422-30.
16. Lachurié ML, Azizi M, Guyene TT, Alhenc-Gelas F, Ménard J. Angiotensin converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin aldosterone system or blood pressure in normotensive subjects. Circulation 1995;91:2933-42.
17. Nussberger J, Brunner DB, Waeber B, Brunner HR. True versus immunoreactive angiotensin II in human plasma. Hypertension 1985;7(suppl I):I-11-7.
18. Cushman DW, Cheung MS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 1971;20:1637-48.
19. Arnal JF, Battle T, Rasetti C, et al. Angiotensin I converting enzyme in the three tunicae of the rat aorta: expression in smooth muscle and effect of renovascular hypertension. Am J Physiol 1994;267:H1777-84.
20. Moncada S, Reed DD, Schulz R, Palmer RM. Development and mechanism of a specific supersensitivity to nitro vasodilatators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci USA 1991;88:2166-70.
21. Danonberg J, Siders RS, Grekin RJ. Sustained hypertension induced by orally administered nitro-L-arginine. Hypertension 1993;21:359-63.
22. Schultz PJ, Schorer AE, Raij L. Effect of endothelium derived relaxing factor and nitric oxide on rat mesangial cells. Am J Physiol 1990;258:F162-8.
23. Ito S, Johnson CS, Carretero QA. Modulation of angiotensin II induced vasoconstriction by endothelium derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 1991;87:1656-63.
24. Hirata M, Kohse KP, Chang CH, Ikebe TJ, Murad F. Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segment and cultured bovine aortic smooth muscle cells. J Biol Chem 19990;265:1268-73.
25. Ruth P, Wang GX, Boekhoff I, et al. Transfected cGMP dependent protein kinase suppresses calcium transients by inhibition of inositol 1,4,5 triphosphate production. Proc Natl Acad Sci USA 1993;90:2623-7.
26. Küng CF, Moreau P, Takase H, Luscher TF. L-NAME hypertension alters endothelial and smooth muscle function in rat aorta: prevention by trandolapril and verapamil. Hypertension 1995;26:744-51.
27. Battle T, Arnal JF, Challah M, Michel JB. Selective isolation of rat aortic wall layers and cells types in culture; application to converting enzyme measurement. Tissue Cell 1994;26:943-55.
28. Rakugi H, Duk-Kyung K, Krieger JE, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest 1994;93:339-46.
29. Fishel RS, Thourani V, Eisenberg SJ, et al. Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. J Clin Invest 1995;95:377-87.
30. Morrell NW, Atochina EN, Morris KG, Danilov S, Stenmark KR. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. J Clin Invest 1995;96:1823-33.
31. Patel JM, Yarid FR, Block ER, Raizada MK. Angiotensin receptors in pulmonary arterial and aortic endothelial cells. Am J Physiol 1989;256:C987-93.
32. Pueyo M, N'Daye N, Michel JB. Angiotensin II elicits signal transduction via AT1 receptors in endothelial cells. Br J Pharmacol 1996 (in press).
33. 1 subtype receptors in the rat carotid artery. Arteriosclerosis 1995;15:1646-51.
34. Beaufils M, Sraer J, Lepreux C, Ardaillou R. Angiotensin II binding to renal glomeruli from sodium-loaded and sodium depleted rats. Am J Physiol 1976;230:1187-93.